The clinicopathologic and molecular profile of second primary thyroid cancer in pediatric cancer survivors
To characterize the clinicopathological and molecular profiles, treatment, and outcomes of second primary thyroid cancer (SPTC) in childhood cancer survivors to inform risk-stratified surveillance and management. This retrospective case series enrolled patients (aged ≤18 years at thyroid cancer diagnosis)...